Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01
· inc., greenwich lifesciences
AI Briefing
- Greenwich LifeSciences adds City of Hope to FLAMINGO-01 clinical trial for breast cancer prevention.
- GLSI-100 immunotherapy to be evaluated in US clinical sites.
- Phase III clinical trial aims to prevent breast cancer recurrences.
Advertisement